Riskpilot← Back to searchSign inGet full accessFysio17 Oy
OYActiveY-tunnus 2592684-6Pl 104Physiotherapy activities · NACE 8695Est. 20131 employees
Revenue 2024
EUR 199K
-1% vs 2023
EBITDA margin
5.6%
-76% vs 2023
Equity ratio
93.3%
Financial strength
Net profit 2024
EUR -9K
-123% vs 2023
| Revenue | EUR 199K | -1% |
| EBITDA | EUR 11K | -76% |
| Net profit | EUR -9K | -123% |
| Total assets | EUR 241K | -10% |
| Equity | EUR 225K | -11% |
| Employees | 1 | — |
Legal name
Fysio17 Oy
Y-tunnus number
2592684-6
Legal form
Osakeyhtiö
NACE code
8695 · Physiotherapy activities
Founded
20. joulukuuta 2013
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on yleistoimiala. Fysioterapia, fysioterapia- ja hierontapalvelut ja siihen liittyvä koulutus- ja myyntitoiminta.
Address
Pl 104
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 138 | 165 | 136 | 175 | 176 | 200 | 199 |
| Staff expenses | −48 | −52 | −57 | −63 | −61 | −73 | −81 |
| EBITDA | 36 | 54 | 17 | 62 | 51 | 47 | 11 |
| Depreciation & amort. | −7 | −5 | — | — | — | −0 | −0 |
| EBIT | 29 | 49 | 17 | 62 | 51 | 47 | 11 |
| Net financials | −1 | −1 | −0 | −0 | 2 | −0 | −17 |
| Profit before tax | 28 | 48 | 17 | 62 | 53 | 47 | −6 |
| Tax | 6 | 10 | 4 | 13 | 11 | 10 | 3 |
| Net profit | 22 | 38 | 14 | 49 | 42 | 37 | −9 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 184 | 205 | 184 | 220 | 249 | 268 | 241 |
| Equity | 148 | 174 | 174 | 210 | 235 | 253 | 225 |
| Long-term debt | — | — | — | — | — | 0 | 0 |
| Short-term debt | 36 | 31 | 10 | 11 | 14 | 15 | 16 |
| Total debt | 36 | 31 | 10 | 11 | 14 | 15 | 16 |
EBITDA margin
5.6%
This company
15.8%
Market median
-65% vs market
20182024
Equity ratio
93.3%
This company
38.2%
Market median
+144% vs market
20182024
Return on equity
-3.8%
This company
18.4%
Market median
-121% vs market
20182024
Net profit margin
-4.4%
This company
8.1%
Market median
-154% vs market
20182024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20182024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20182024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JK Deputy Member | Deputy Member | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2014 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fysio17 Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jorma Kasperi Pitkäkangas | Deputy Member | 0 companies |
| Ismo Veikko Palmamäki | Board of Directors | 0 companies |